Description
Dr. Eric Murillo-Rodrguez is Psychologist and holds a PhD. in Biomedical Sciences, both degrees obtained by the National Autonomous University of Mexico (UNAM). Upon graduation, he completed his postdoctoral training at Harvard Medical School. His scientific contribution includes over 70 peer-reviewed publications in various reputed scientific and medical journals, 10 chapters in books. He is an active member of several scientific societies and the editorial board members of various journals. Details of his publications can be viewed at ResearchGate: https://www.researchgate.net/profile/Eric_Murillo-Rodriguez S. R. Pandi-Perumal, MSc, is the President and Chief Executive Officer of Somnogen Canada Inc, a Canadian Corporation. He is a well-recognized sleep researcher and has authored over 200 publications. His general area of research interest includes sleep and biological rhythms. He has edited over 25 volumes dealing with various sleep-related topics. His online biography can be viewed at http://pandi-perumal.blogspot.com Jaime Monti, MD, is associated with the University of the Republic, Uruguay. He has completed post-doctoral studies at the National Institute of Health, USA. He is full Professor of Pharmacology and Therapeutic and the School of Medicine of the Republic University, Professor of the Basic Sciences Development Program (PEDECIBA) and Researcher the National Researchers’ System. He is a globally recognized sleep researcher and has been awarded with the prestigious Claude Bernard Prize (French Governemnt) and with the Schering Award for Basic Sleep Research (USA). He is an international recognized expert in the neuropharmacology of sleep and wakefulness, with more than two hundred publications in this field. – Constituents of Cannabis Sativa. – Neuromolecular Mechanisms of Cannabis Action. – Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review. – Emerging Roles of Cannabinoids and Synthetic Cannabinoids in Clinical Experimental Models. – Cannabis and Depression. – Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer’s, Parkinson’s, and Huntington’s Diseases. – Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders. – Cannabinoid-Based Medicines and Multiple Sclerosis. – Psychiatric Disorders and Cannabinoid Receptors.
